Advertisement · 728 × 90

Posts by Pascalis Vergidis, MD

Post image Post image

Bismarck Bisono presenting @escmid.bsky.social on invasive aspergillosis in patients with chronic lymphocytic leukemia

2 days ago 1 0 0 0
Post image

Y ou know about invasive aspergillosis in AML. Do you want to learn what happens in Chronic Lymphocytic Leukemia?
Dr. Bismarck Bisono will discuss risk factors and outcomes.
First presentation in IFI session @escmid.bsky.social

6 days ago 2 0 0 0

Mary Bowden, MD was fired by her own institution for prescribing ivermectin to treat Covid-19 (among other reasons). She has recently drawn attention for targeting doctors starting their training. We (as medical community) are not obligated to engage with or amplify her posts.

3 weeks ago 0 0 0 0
Preview
Summary for Patients: Long-Term Mpox Sequelae 11 to 18 Months After Acute Illness | Annals of Internal Medicine

Long term Mpox sequelae

www.acpjournals.org/doi/10.7326/...

3 weeks ago 0 0 0 0

Serofast in syphilis refers to a state where patients have persistently reactive nontreponemal test titers despite successful treatment, without evidence of treatment failure or reinfection.

3 weeks ago 1 0 0 0
Post image

Department of Medicine Staff Awards @mayocliniccancer.bsky.social

Honored to be a Member of the amazing CAR-T cell therapy team.

2 months ago 0 0 0 0
Post image Post image

Mycology Lab for the medical students at Mayo Clinic Alix School of Medicine. We reviewed morphological differences between Aspergillus and Mucorales.

2 months ago 4 0 1 0
Post image

Included in this year’s Mycology Lecture for the medical students at Mayo Clinic Alix School of Medicine.
Trichophyton indotinae, an emerging fungal threat

3 months ago 0 0 0 0
Advertisement
Post image Post image
3 months ago 0 0 0 0
Post image

Microbiology course at Mayo Clinic Alix School of Medicine. We reviewed 4 case of tuberculosis with a focus on social determinants of health.

Excellent discussion led by our social worker, Mariah Thompson, and Dr. Zami Temesgen, principal investigator Mayo Clinic Center for Tuberculosis.

3 months ago 3 0 2 0
Post image Post image Post image

Bacteriology Lab for the medical students at Mayo Clinic Alix School of Medicine led by Dr. Bobbi Pritt.

We had 12 stations. All about Gram stains and cultures! Note the green metallic sheen of E. coli on Eosin Methylene Blue (EMB) agar.

3 months ago 2 0 1 0
Post image

Introduction to Microbiology for the medical students at the Mayo Clinic Alix School of Medicine

We discussed this MMWR publication which brought us back to the onset of the #HIV epidemic.

3 months ago 4 0 1 0
Preview
Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial - PubMed French Ministry of Health.

pubmed.ncbi.nlm.nih.gov/40652952/

4 months ago 0 0 0 0
Post image

Looking forward to our journal club #MayoClinic Infectious Disease Fellowship. Adjunctive corticosteroids in hypoxemic patients with non-HIV Pneumocystis pneumonia. No difference in 28-day mortality. However, need for mechanical ventilation was lower in the steroid group.

4 months ago 5 0 2 0
Post image

As a member of the ABIM Infectious Disease Approval Committee, I would like to congratulate those who recently passed their Boards. You are all committed to delivering exceptional patient care and upholding the highest standards in Medicine.

4 months ago 3 0 1 0
Post image Post image

How best to treat invasive aspergillosis? @pascalisid.bsky.social reviewing key clinical studies informing this choice - important to monitor vori levels , NB: AmB <vori=isavu @idweek.bsky.social #IDWeek2025 #TxID #IDSky

6 months ago 5 1 1 0
Post image

Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.

6 months ago 10 2 3 0
Preview
Home - Doctor Fungus Welcome to Doctor Fungus! An Educational Website of theMycoses Study Group Education and Research Consortium (MSGERC)   [View Legal Information] Where to Start Mycology Case of the Month An Introducti...

There’s now an app for all things fungi 🦠🍄
Dr. Matthew Pullen, Assistant Professor at the University of Minnesota, helped launch Dr Fungus—a free app that brings the trusted resource to your phone.

Explore fungal infections, antifungal treatments, and case-based learning—all in one place.

6 months ago 43 16 2 2
Advertisement
Post image

🆕 MMWR: In NYC, NDM-CRE just surpassed KPC-CRE for the first time.

And nearly 75% of these cases had no long-term care facility link

This is a changing landscape of antibiotic resistance - happening across US

#IDSky
📄: www.cdc.gov/mmwr/volumes...

9 months ago 8 3 3 1
Lateral flow device showing positive control (line at C but not T), negative control (line at both C and T), and a test sample (lines at both C and T shown). The test line (T) disappears when the antigen is present.

Lateral flow device showing positive control (line at C but not T), negative control (line at both C and T), and a test sample (lines at both C and T shown). The test line (T) disappears when the antigen is present.

ROC for the lateral flow device for mucorales antigen TG-11. The AUC is 0.739

ROC for the lateral flow device for mucorales antigen TG-11. The AUC is 0.739

Detection of Mucorales antigen in BAL samples using a newly developed lateral-flow device

A Mucorales antigen test is sorely needed

This one had Sn of 76.92%, Sp of 75.51%, respectively, PPV 45.45%, and a NPV 92.5% (Not good enough but could augment qPCR)

journals.asm.org/doi/10.1128/...

10 months ago 22 8 2 0
Post image

Join us for a panel discussion on “Leveraging Partnerships to Fight Fungal Diseases” June 19
2.55-3.25 pm @ASMicrobiology
Dallas Smith @CDCgov
Sean Zhang, Fungal Diagnostics Laboratory Consortium
Rob Purdie, MYCology Advocacy, Research & Education
Zachary Rubin @lapublichealth
Me @MSG_ERC

10 months ago 5 1 2 0
Post image

Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee.

Of the profession, for the public

10 months ago 3 0 1 0
Preview
Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review Cytomegalovirus-specific T cells have been used in studies of primarily adult hematopoietic stem cell transplant recipients. Heterogenous trial design and

Synthesis of the available literature on the use of CMV-specific T-cell therapy in adult and pediatric HSCT and SOT recipients.
Several patients on concurrent antivirals, which confounded the effectiveness of VSTs
@CIDJournal @transplantidnet.bsky.social

academic.oup.com/cid/advance-...

10 months ago 5 0 0 1
Post image

Dr. Jeniel Nett discussing biofilm at the 2025 Scientific Meeting on Candida auris @msgerc.bsky.social

10 months ago 2 0 0 0
Preview
Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With Human Immunodeficiency Virus in the United States The prevalence of Kaposi sarcoma–associated herpesvirus (KSHV) was high among kidney donor and transplant recipients with HIV. Posttransplant KSHV-associat

High Kaposi sarcoma-associated herpesvirus seroprevalence in donors and recipients with HIV, particularly among MSM. Reassuringly, disease was rare.
@transplantidnet.bsky.social

academic.oup.com/cid/advance-...

10 months ago 2 0 0 0
Advertisement
Preview
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY) AbstractBackground. We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant imm

In a phase 3 clinical trial, pemivibart provided prophylactic efficacy against COVID-19 in immunocompromised patients and individuals at risk for exposure. Four of 623 participants experienced anaphylactic reactions @transplantidnet.bsky.social

academic.oup.com/cid/advance-...

10 months ago 3 0 0 0
Line graph showing year-to-year fluctuation but general increase in fluconazole resistance (lowest was 6% in 2018, highest was 21% in 2024), with slight increase in voriconazole and posaconazole resistance (up to 5% in 2024), and micafungin resistance that briefly reached 5% in 2023 before dropping again

Line graph showing year-to-year fluctuation but general increase in fluconazole resistance (lowest was 6% in 2018, highest was 21% in 2024), with slight increase in voriconazole and posaconazole resistance (up to 5% in 2024), and micafungin resistance that briefly reached 5% in 2023 before dropping again

Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015–2024)

Fluco-R C parapsilosis ⬆️ from 8.2% to 20.3% in BCx isolates tested @ Mayo

Jack McHugh ... @pascalisid.bsky.social

academic.oup.com/jid/advance-...

11 months ago 6 2 0 0

This #TransDayofVisibility 🏳️‍⚧️

Please know:

We see you, & we will continue to fight for you.

1 year ago 10 3 0 0
Post image

ID Grand Rounds.

I discussed the following:
- ONE Health
- Aspergillus urine antigen
- Giant magnetoresistance-enabled PCR
- Rezafungin for prevention in bone marrow transplant
- Ibrexafungerp (FURI)
- Olorofim (Study 32)
- Our experience with fosmanogepix

1 year ago 6 0 0 0

In rare cases, vaping-associated lung injury (EVALI) may lead to irreversible damage requiring lung transplantation

1 year ago 1 0 0 0